Melanoma coordinates general and cell-specific mechanisms to promote methotrexate resistance-Reference-Cited by-同舟云学术

Melanoma coordinates general and cell-specific mechanisms to promote methotrexate resistance

Published:2012-06 Issue:10 Volume:318 Page:1146-1159
ISSN:0014-4827
Container-title:Experimental Cell Research
language:en
Short-container-title:Experimental Cell Research

Author:

Sáez-Ayala Magalí,Fernández-Pérez María Piedad,Montenegro María F.,Sánchez-del-Campo Luis,Chazarra Soledad,Piñero-Madrona Antonio,Cabezas-Herrera Juan,Rodríguez-López José Neptuno

Publisher

Elsevier BV

Subject

Cell Biology

Reference40 articles.

1. Molecular basis of antifolate resistance;Assaraf;Cancer Metastasis Rev.,2007

2. The DNA damage checkpoint is activated during residual tumour cell survival to methotrexate treatment as an initial step of acquired drug resistance;de Anta;Anticancer Drugs,2006

3. Natural resistance to methotrexate in human melanomas;Kufe;J. Invest. Dermatol.,1980

4. Melanosomal sequestration of cytotoxic drugs contributes to the intractability of malignant melanomas;Chen;Proc. Natl. Acad. Sci. U. S. A.,2006

5. The critical role of alpha-folate receptor in the resistance of melanoma to methotrexate;Sánchez-del-Campo;Pigment Cell Melanoma Res.,2009

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A comprehensive review on methotrexate containing nanoparticles; an appropriate tool for cancer treatment;Molecular Biology Reports;2022-09-12

2. Much more than you expected: The non-DHFR-mediated effects of methotrexate;Biochimica et Biophysica Acta (BBA) - General Subjects;2017-03

3. Resistance to ursolic acid-induced apoptosis through involvement of melanogenesis and COX-2/PGE2 pathways in human M4Beu melanoma cancer cells;Experimental Cell Research;2016-07

4. Mechanisms of tumour resistance against chemotherapeutic agents in veterinary oncology;The Veterinary Journal;2016-01

5. Methotrexate-conjugated quantum dots: synthesis, characterisation and cytotoxicity in drug resistant cancer cells;Journal of Drug Targeting;2015-07-15